Public-Private Partnerships for Vaccine Research

Public-private partnerships (PPPs) have emerged as an effective model for vaccine research and development. These partnerships bring together the expertise and resources of both the public and private sectors to accelerate the development of vaccines and improve access to them. PPPs can help to bridge the funding gap for vaccine development, share risks and rewards, and ensure that vaccines are affordable and accessible to all. They also facilitate collaboration between industry, academia, and government, leading to innovation and discovery. The success of PPPs in vaccine development highlights the importance of collaboration and cooperation in achieving global health goals.

    Related Conference of Public-Private Partnerships for Vaccine Research

    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    October 31-01, 2024

    36th International Conference on Vaccines and Immunization

    Amsterdam, Netherlands
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France
    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France

    Public-Private Partnerships for Vaccine Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in